Key Highlights
- Glooko raises $100M in Series F funding led by Georgian, with participation from Health Catalyst Capital and Canaan.
- Mike Alvarez appointed as CEO, bringing over two decades of healthcare leadership experience.
- Financing to drive product expansion in data insights, device integration, and chronic condition support.
- Glooko aims to accelerate global digital healthcare platform and clinical research growth.
Source: Business Wire
Notable Quotes
- “We believe Mike is the right leader at a key inflection point for Glooko and look forward to working with him.” — Simon Chong, Co-Founder at Georgian and Chairman of the Board of Directors at Glooko
- “By unifying data from multiple devices onto one standardized platform, we can simplify decision-making and empower providers to translate vast amounts of data into meaningful insights.” — Mike Alvarez, CEO at Glooko
SoHC's Take
This significant investment signals Glooko’s strong market position and the growing demand for digital health solutions, especially in chronic disease management. With Mike Alvarez’s expertise in medical technology and chronic condition care, Glooko is poised for accelerated innovation and expanded global impact. The Series F funding will likely fuel advancements in clinical workflows and healthcare data integration, making Glooko a key player in improving patient outcomes through real-time, actionable insights.
